Trials / Withdrawn
WithdrawnNCT01890902
Efficacy and Safety of Impracor (Ketoprofen 10% Cream) Compared With Placebo in the Treatment of Acute Pain (Flare) Associated With Osteoarthritis of the Knee
A Randomized, Multicenter, Double-Blind, Parallel-Group Study to Assess the Efficacy and Safety of Impracor (Ketoprofen 10% Cream) Compared With Placebo in the Treatment of Acute Pain (Flare) Associated With Osteoarthritis of the Knee
- Status
- Withdrawn
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Imprimis Pharmaceuticals, Inc. · Industry
- Sex
- All
- Age
- 35 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of the study is to assess analgesic efficacy of Impracor (Ketoprofen 10% Cream) compared to placebo for acute pain associated with OA flare of the knee.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ketoprofen 10% Cream | |
| DRUG | Placebo |
Timeline
- Start date
- 2013-08-01
- Primary completion
- 2014-06-01
- First posted
- 2013-07-02
- Last updated
- 2013-11-13
Source: ClinicalTrials.gov record NCT01890902. Inclusion in this directory is not an endorsement.